Bay Area biotech company says it's using AI to make cell therapy more accessible
Cell therapies have shown promise in treating some cancers, blood disorders and autoimmune diseases.
Read the original →Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.

Cell therapies have shown promise in treating some cancers, blood disorders and autoimmune diseases.
Read the original →A team led by the MIT Media Lab's Advancing Humans with AI (AHA) program has launched ImpactBench. It worked with UC Berkeley Haas, the USC Marshall's Neely Center for Ethical Leadership and Decision Making, and the Psychology of Technology Institute. ImpactBench is an expert-guided, open, and evolving evaluation framework for measuring AI's impact on human wellbeing.
Read the original →Korea has warned people against using generative AI chatbots to diagnose depression or other mental illnesses. A government survey found that one in three respondents who rated their mental health as poor had treated AI assessments as medical diagnoses.
Read the original →Researchers at the University of Delaware have launched a new AI institute. It aims to develop technology that can assist clinicians and physical therapists in delivering more personalized care.
Read the original →The article notes that being too sedentary contributes to poor health and may worsen pain. It says many people still spend long periods sitting while watching TV, scrolling on phones, or working at a computer.
Read the original →A five-year program centered at the University of Delaware will explore how AI could help medical experts improve physical rehabilitation.
Read the original →Agrifood experts say AI is rapidly transforming operations in the sector, helping companies identify innovative technologies quicker and enabling shorter product cycles. They say whether AI is useful still comes down to meticulous planning and execution.
Read the original →iM Securities raised its target price for Hanmi Pharmaceutical from ₩600,000 to ₩650,000 (approximately $490). It maintained a buy rating.
Read the original →A 2024 study claimed high-accuracy deep learning detection of ovarian cancer. It was retracted after its ultrasound dataset was found to contain images that may be of thyroid rather than ovarian tissue.
Read the original →Prof. Olusegun Alatise, Head of the Department of Surgery at Obafemi Awolowo University Teaching Hospital Complex (OAUTHC) in Ile-Ife, says the African Research Group for Oncology (ARGO) is advancing cancer care through AI, precision medicine and research. Alatise is the Convener of the 12th Annual International Oncology Symposium.
Read the original →Left ventricular diastolic dysfunction (LVDD) is described as a key pathophysiological feature of heart failure with preserved ejection fraction (HFpEF).
Read the original →The market outlook to 2035 says growth is driven by screening for diabetes-related retinopathy and AI-enabled portable devices. Software and workflow integration are reshaping demand.
Read the original →Kazakhstan is testing an AI system that can detect the risk of heart failure at an early stage using an electrocardiogram.
Read the original →Desert Radiology uses two AI tools as demand for medical imaging rises.
Read the original →U.S. electricity consumption is forecast to set successive records this year and next. Commercial demand growth, led by AI data centers, is raising pressure on power consumption and prices. Market observers warn of a severe shortage of critical power infrastructure, with aging equipment, supply-chain bottlenecks and grid-interconnection delays widening the lag between new generating facilities and power delivery.
Read the original →The description says the church has some experience with millenarian cults.
Read the original →A retinal AI model reported in Nature Biotechnology detects risk of preeclampsia and gestational hypertension non-invasively.
Read the original →Employee satisfaction and engagement were rarely cited as key factors of organizational success 20 years ago, but today's executives see people as the most powerful drivers of business performance. Gallup's most recent State of the American Workplace report confirms that high engagement levels correlate with higher productivity, profitability and sales.
Read the original →Courier Inc. announced on October 7 that it began providing an interactive AI chatbot specialized in elderly and nursing care in Adachi Ward, Tokyo, on October 1. It describes the initiative as the first in Tokyo's 23 wards. The service is available 24 hours a day, 365 days a year, including nights and holidays outside ward office hours.
Read the original →Goodtree Inc., based in Sendai, Miyagi Prefecture, announced that its cloud-based care software has been registered as an eligible IT tool under the 2026 Digitalization and AI Adoption Subsidy. The company says it is working with kubell to support care-sector digital transformation using the subsidy.
Read the original →